LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 211 filers reported holding LEGEND BIOTECH CORP in Q4 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $53,294,511 | -52.1% | 1,203,308 | -39.3% | 2.04% | -47.9% |
| Q1 2024 | $111,170,717 | -2.5% | 1,982,006 | +4.6% | 3.91% | -26.7% |
| Q4 2023 | $114,000,729 | -16.2% | 1,894,644 | -6.5% | 5.34% | -42.2% |
| Q3 2023 | $136,051,492 | +9.1% | 2,025,480 | +12.2% | 9.23% | -4.2% |
| Q2 2023 | $124,648,645 | +71.2% | 1,805,717 | +19.6% | 9.63% | +39.6% |
| Q1 2023 | $72,827,823 | +38.3% | 1,510,324 | +43.2% | 6.90% | +11.7% |
| Q4 2022 | $52,659,110 | +19.9% | 1,054,870 | -2.0% | 6.18% | +5.5% |
| Q3 2022 | $43,925,000 | -18.4% | 1,076,591 | +10.0% | 5.86% | -45.4% |
| Q2 2022 | $53,823,000 | +78.1% | 978,596 | +17.7% | 10.73% | +34.3% |
| Q1 2022 | $30,225,000 | +68.0% | 831,728 | +115.5% | 7.99% | +55.5% |
| Q4 2021 | $17,990,000 | – | 385,967 | – | 5.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 560,506 | $26,125,000 | 18.14% |
| JOHNSON & JOHNSON | 1,629,173 | $75,936,000 | 8.64% |
| HHLR ADVISORS, LTD. | 11,804,925 | $550,228,000 | 8.50% |
| Paradigm Biocapital Advisors LP | 385,967 | $17,990,000 | 5.14% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,004,742 | $46,831,000 | 4.89% |
| Yong Rong (HK) Asset Management Ltd | 130,000 | $6,060,000 | 4.79% |
| Old Well Partners, LLC | 79,700 | $3,715,000 | 2.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,322,000 | 1.88% |
| Tri Locum Partners LP | 89,840 | $4,187,000 | 1.65% |
| INDUS CAPITAL PARTNERS, LLC | 123,054 | $5,736,000 | 1.36% |